Trial Profile
A pilot study on prevention of glucocorticoid induced diabetes mellitus by linagliptin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2020
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms P-GDM-Lina
- 06 Nov 2020 Status changed from recruiting to completed.
- 07 May 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 27 Dec 2014 New trial record